Press Releases April 22, 2026 04:15 PM

Dentsply Sirona to Host First Quarter 2026 Conference Call on May 5

Dentsply Sirona schedules Q1 2026 earnings call for May 5, 2026

By Hana Yamamoto
Share
Twitter Reddit Facebook LinkedIn
XRAY

Dentsply Sirona Inc., a leading manufacturer of dental products and technologies, announced it will hold its first quarter 2026 financial results conference call and webcast on May 5, 2026. Earnings materials will be available on the company website prior to the call.

Dentsply Sirona to Host First Quarter 2026 Conference Call on May 5
XRAY
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Dentsply Sirona is the largest diversified manufacturer in the professional dental products sector.
  • The company will discuss its Q1 2026 financial results in an investor call, indicating continued transparency.
  • Dentsply Sirona operates in dental technology and consumable medical device sectors impacting healthcare and medical technology markets.

CHARLOTTE, N.C., April 22, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and live webcast on Tuesday, May 5, 2026, at 4:30 p.m. ET to review its first quarter 2026 financial results. Financial earnings materials will be made available on the Investors section of the Company’s website at https://investor.dentsplysirona.com prior to the call.

Conference Call / Webcast Information

The live webcast link and call information will be available on the Investors section of the Company’s website at https://investor.dentsplysirona.com. For those planning to participate on the call, please register here. A webcast replay of the conference call will be available on the Investors section of the Company’s website following the call.

About Dentsply Sirona

Dentsply Sirona is the world’s largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world-class brands. Dentsply Sirona’s innovative products provide high-quality, effective and connected solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona is headquartered in Charlotte, North Carolina. The Company’s shares are listed in the United States on Nasdaq under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.

Contact Information

Investors:
Wade Moody
Senior Manager, Investor Relations
[email protected]


Risks

  • Uncertainty around Q1 2026 financial performance, which could affect investor sentiment.
  • Potential impact of healthcare industry regulations on dental product manufacturers.
  • Market dynamics and competition within the dental products and medical device sectors that could influence company growth.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026